Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical and genetic modifiers of long-term survival in heart failure.

Journal of the American College of Cardiology - 28 Jul 2009

Cresci Sharon, Kelly Reagan J, Cappola Thomas P, Diwan Abhinav, Dries Daniel, Kardia Sharon L R, Dorn Gerald W

Abstract excerpt

OBJECTIVES: This study sought to identify genetic modifiers of beta-blocker response and long-term survival in heart failure (HF). BACKGROUND: Differences in beta-blocker treatment effect between Caucasians and African Americans with HF have been reported. METHODS: This was a prospective cohort s...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenergic beta-Antagonists
Share to Black or African American
Share to Cohort Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Heart Failure

Share to Receptors, Adrenergic, beta

Share to Survival Rate

Share to Treatment Outcome

Share to White People

Source

Open in PubMed Open full text

Identifiers

PMID: 19628119
DOI: 10.1016/j.jacc.2009.05.009
PMCID: PMC2749467

Genes

ADRB1
GRK5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19628119-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical and genetic modifiers of long-term survival in heart failure.PMID 19628119Read ↗

The Beta-Blocker Pharmacogenetic Puzzle: More Pieces of Evidence for Pharmacodynamic Candidate Variants.Semantic proximity Read ↗

β-adrenergic receptor polymorphisms in susceptibility, response to treatment and prognosis in heart failure: implication of ethnicity.Semantic proximity Read ↗

β1 adrenergic receptor polymorphisms and heart failure: a meta-analysis on susceptibility, response to β-blocker therapy and prognosis.Semantic proximity Read ↗

Pharmacogenomics of heart failure.Semantic proximity Read ↗

Association of β-Blocker Exposure With Outcomes in Heart Failure Differs Between African American and White PatientsSemantic proximity Read ↗

Genetic polymorphisms in ADRB2 and ADRB1 are associated with differential survival in heart failure patients taking β-blockers.Semantic proximity Read ↗

Polygenic Score for β-Blocker Survival Benefit in European Ancestry Patients With Reduced Ejection Fraction Heart Failure.Semantic proximity Read ↗

Effects of GRK5 and ADRB1 polymorphisms influence on systolic heart failure.Semantic proximity Read ↗

A GRK5 polymorphism that inhibits beta-adrenergic receptor signaling is protective in heart failure.Semantic proximity Read ↗

Association of beta-adrenergic receptor polymorphisms and mortality in carvedilol-treated chronic heart-failure patients.Semantic proximity Read ↗

Beta2-adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an acute coronary syndrome.Semantic proximity Read ↗

Review: Heart failure with preserved ejection fraction in African Americans.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.